Top 5 Xeris Glucagon Product Attributes You Must Know
Abstract: Xeris glucagon leverages proprietary G-Pump® technology to address critical stability and usability gaps in the peptide market. Unlike traditional lyophilized powders requiring reconstitution, Xeris’ ready-to-use liquid formulation offers superior shelf-life (24 months at room temperature) and rapid onset (10-15 minutes). Comparative analysis against Eli Lilly and Zealand Pharma highlights Xeris’ advantage in needle-free delivery and reduced dosing errors. With the global glucagon market projected at $4.2B by 2030 (CAGR 8.5%), Xeris’ cGMP-certified manufacturing and FDA-approved Baqsimi® and Gvoke® products set a benchmark for peptide logistics and patient compliance. Key attributes include non-refrigerated stability, auto-injector precision, and dual-use for severe hypoglycemia and diagnostic imaging.